Lv4
486 积分 2026-02-04 加入
Anti-CLEC7A nanobody in situ engineering promotes amyloid-β oligomers clearance by CAR-microglia to alleviate Alzheimer's disease pathology in mice
2个月前
已完结
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy
2个月前
已完结
Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses
3个月前
已完结
Cell therapy with human interleukin 10–producing ILC2s enhances islet function and inhibits allograft rejection
3个月前
已关闭
Single-cell profiling of immune reset in patients with refractory generalized myasthenia gravis receiving autologous CD19/BCMA CAR-T cell therapy
3个月前
已完结
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
3个月前
已完结
Batoclimab vs Placebo for Generalized Myasthenia Gravis
3个月前
已完结
An International Perspective on Preceding Infections in Guillain-Barré Syndrome
3个月前
已完结
Antiviral therapy with tenofovir in MS
3个月前
已关闭
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
4个月前
已完结
皖公网安备34019202002308
